<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nogr-433</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>ИЗМЕНЕНИЯ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА У ПАЦИЕНТОВ С ЯЗВЕННЫМ КОЛИТОМ</article-title><trans-title-group xml:lang="en"><trans-title>CHANGES OF INTESTINAL MICROBIOTA IN PATIENTS WITH ULCERATIVE COLITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilova</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдулхаков</surname><given-names>С. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdulkhakov</surname><given-names>S. R.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoryeva</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркелова</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Markelova</surname><given-names>M. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павленко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlenko</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тяхт</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyakht</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубинкина</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubinkina</surname><given-names>V. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кострюкова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostryukova</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларин</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Larin</surname><given-names>A. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скородумова</surname><given-names>Л. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Skorodumova</surname><given-names>L. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манолов</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Manolov</surname><given-names>A. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Одинцова</surname><given-names>А. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Odintsova</surname><given-names>A. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдулхаков</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdulkhakov</surname><given-names>R. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет; Казанский федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan Federal University; Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Казанский федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение федеральный научно-клинический центр физико-химической медицины федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Centre of Physical-Chemical Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Московский физико-технический институт</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Institute of Physics and Technology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Республиканская клиническая больница МЗ РТ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2017</year></pub-date><volume>0</volume><issue>6</issue><fpage>54</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Данилова Н.А., Абдулхаков С.Р., Григорьева Т.В., Маркелова М.И., Павленко А.В., Тяхт А.В., Дубинкина В.Б., Кострюкова Е.С., Ларин А.К., Скородумова Л.О., Манолов А.И., Одинцова А.Х., Абдулхаков Р.А., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Данилова Н.А., Абдулхаков С.Р., Григорьева Т.В., Маркелова М.И., Павленко А.В., Тяхт А.В., Дубинкина В.Б., Кострюкова Е.С., Ларин А.К., Скородумова Л.О., Манолов А.И., Одинцова А.Х., Абдулхаков Р.А.</copyright-holder><copyright-holder xml:lang="en">Danilova N.A., Abdulkhakov S.R., Grigoryeva T.V., Markelova M.I., Pavlenko A.V., Tyakht A.V., Dubinkina V.B., Kostryukova E.S., Larin A.K., Skorodumova L.O., Manolov A.I., Odintsova A.K., Abdulkhakov R.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/433">https://www.nogr.org/jour/article/view/433</self-uri><abstract><p>Цель исследования: изучить особенности кишечной микробиоты у пациентов с язвенным колитом. Материалы и методы исследования: в исследование были включены 46 пациентов с язвенным колитом (25 мужчин и 21 женщина, средний возраст пациентов - 42,4±13,8 лет, длительность заболевания: 5,4 ± 8,2 лет). Для анализа были использованы результаты секвенирования образцов кала пациентов с язвенным колитом и 96 здоровых добровольцев. Полногеномное секвенирование осуществлялось на платформе SOLiD 5500 W (Life Technologies, Foster City, CA, USA). Результаты: метагеномный анализ позволил детектировать в составе микробиоты кишечника у пациентов с язвенным колитом 29 классов бактерий, в том числе: 73 семейства, 154 рода, 437 вида микроорганизмов. На прокариотическую часть микробиоты приходится 99,5 % (из них 98,2 % - Bacteria, 1,8 % - Archaea), на вирусы - 0,5 %, эукариоты - 0,004 %. Таксономический анализ выявил изменения у пациентов с язвенным колитом по сравнению с группой контроля в относительной представленности бактериальных семейств: наблюдалось снижение Lachnospiraceae, Rikenellaceae, Acidaminococcaceae, Enterococcaceae, Desulfovibrionaceae, Verrucomicrobiaceae, Clostridiaceae и увеличение Enterobacteriaceae. Cреди представителей семейства Enterobacteriaceae значимо отличался только род Escherichia, вид Escherichia coli. У пациентов с язвенным колитом представленность Escherichia составила (3,74±8,01)% и была больше, чем в группе контроля - (1,49±5,23)%, тогда как содержание Clostridium - (1,15±3,35)% - было значительно меньше у пациентов с язвенным колитом, чем в группе контроля - (2,33±4,26)%. При анализе биообразцов пациентов с язвенным колитом обнаружено снижение по сравнению с группой контроля индекса альфа-разнообразия, который характеризует богатство микробного сообщества. Выводы: у пациентов с язвенным колитом выявлены значительные изменения таксономического состава микробиоты по сравнению с образцами контрольной группы.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to evaluate the representation of the microbial community in patients with ulcerative colitis. Materials and methods. The study included 46 patients with ulcerative colitis (25 men and 21 women, aged 42,4±13.8 years, duration of the disease - 5,42 ±8.21 years). Results of sequencing of ulcerative colitis patients stool samples as well as samples from 96 healthy volunteers were used for analysis. Whole genome sequencing was carried out on the SOLiD 5500W platform (LifeTechnologies, FosterCity, CA, USA). Results. Metagenomic analysis allowed us to detect 29 classes of bacteria, including: 73 families, 154 genera, 437 species of microbes in intestinal microbiota of patients with ulcerative colitis. The prokaryotic part of microbiota formed 99.5 % (98,2 % - Bacteria, 1,8 % - Archaea), viruses - 0.5 %, eukaryotes - 0,004 % of all intestinal microbiota. Taxonomic analysis revealed changes in the relative representation of bacterial families: we observed decrease in Lachnospiraceae, Rikenellaceae, Acidaminococcaceae, Enterococcaceae, Desulfovibrionaceae, Verrucomicrobiaceae, Clostridiaceae and increase in Enterobacteriaceae. Only the number of Escherichia genus, particularly Escherichia coli species was significantly abundant among the members of Enterobacteriaceae family. In ulcerative colitis patients the fraction of Escherichia was (3,74±8,01)% which was greater than in the control group (1,49±of 5.23)%, whereas the fraction of Clostridium (1,15±3,35)% was significantly lower in patients with ulcerative colitis than in the control group (2,33±4,26)%. The alpha-diversity index which characterizes richness of the microbial community was decreased in stool samples of patients with ulcerative colitis in comparison with the control group. Conclusions. The metagenomics analysis revealed significant changes in intestinal microbiota in ulcerative colitis patients comparing with the control group.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробиота</kwd><kwd>язвенный колит</kwd><kwd>воспалительные заболевания кишечника</kwd><kwd>метагеном</kwd></kwd-group><kwd-group xml:lang="en"><kwd>intestinal microbiota</kwd><kwd>ulcerative colitis</kwd><kwd>inflammatory bowel diseases</kwd><kwd>metagenome</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Li KY, Wei JP, Gao SY, et al. Fecal microbiota in pouchitis and ulcerative colitis. World Journal of Gastroenterology. 2016; 22(40):8929-8939. doi: 10.3748/wjg.v22.i40.8929</mixed-citation><mixed-citation xml:lang="en">Li KY, Wei JP, Gao SY, et al. Fecal microbiota in pouchitis and ulcerative colitis. World Journal of Gastroenterology. 2016; 22(40):8929-8939. doi: 10.3748/wjg.v22.i40.8929</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Presley LL, Ye J, Li X, et al. Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis. 2012 Mar; 18(3):409-417. doi: 10.1002/ibd.21793.</mixed-citation><mixed-citation xml:lang="en">Presley LL, Ye J, Li X, et al. Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis. 2012 Mar; 18(3):409-417. doi: 10.1002/ibd.21793.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ganji L, Alebouyeh M, Shirazi MH, et al. Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis. Gastroenterol Hepatol Bed Bench. 2016 Autumn; 9(4):325-330.</mixed-citation><mixed-citation xml:lang="en">Ganji L, Alebouyeh M, Shirazi MH, et al. Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis. Gastroenterol Hepatol Bed Bench. 2016 Autumn; 9(4):325-330.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Vrakas S, Mountzouris KC, Michalopoulos G, et al. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLoS One. 2017; 12(1): e0170034. doi:10.1371/ journal.pone.0170034</mixed-citation><mixed-citation xml:lang="en">Vrakas S, Mountzouris KC, Michalopoulos G, et al. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLoS One. 2017; 12(1): e0170034. doi:10.1371/ journal.pone.0170034</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ситкин С. И., Вахитов Т. Я., Ткаченко Е. И. и соавт. Микробиота кишечника при язвенном колите и целиакии // Экспериментальная и клиническая гастроэнтерология. - 2017. - № 1(137). - С. 8-30.</mixed-citation><mixed-citation xml:lang="en">Ситкин С. И., Вахитов Т. Я., Ткаченко Е. И. и соавт. Микробиота кишечника при язвенном колите и целиакии // Экспериментальная и клиническая гастроэнтерология. - 2017. - № 1(137). - С. 8-30.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник Л. Б., Конев Ю. В. Новое понимание роли микробиоты в патогенезе метаболического синдрома. // Consilium Medicum. (Прил.). - 2014. - 08. - с. 77-82.</mixed-citation><mixed-citation xml:lang="en">Лазебник Л. Б., Конев Ю. В. Новое понимание роли микробиоты в патогенезе метаболического синдрома. // Consilium Medicum. (Прил.). - 2014. - 08. - с. 77-82.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Мечников И. И. Этюды оптимизма. М.: Наука, 1964. - 128 с.</mixed-citation><mixed-citation xml:lang="en">Мечников И. И. Этюды оптимизма. М.: Наука, 1964. - 128 с.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nissle A. Explanations of the significance of colonic dysbacteria &amp; the mechanism of action of E. coli therapy (mutaflor) Medizinische. 1959; 4:1017-1022.</mixed-citation><mixed-citation xml:lang="en">Nissle A. Explanations of the significance of colonic dysbacteria &amp; the mechanism of action of E. coli therapy (mutaflor) Medizinische. 1959; 4:1017-1022.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Quigley EMM. Gut Bacteria in Health and Disease. Gastroenterol Hepatol (NY). 2013 Sep.; 9(9):560-569.</mixed-citation><mixed-citation xml:lang="en">Quigley EMM. Gut Bacteria in Health and Disease. Gastroenterol Hepatol (NY). 2013 Sep.; 9(9):560-569.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2014 Dec; 13(6):17-22.</mixed-citation><mixed-citation xml:lang="en">Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2014 Dec; 13(6):17-22.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Costello EK, Lauber CL, Hamady M, et al. Bacterial Community Variation in Human Body Habitats Across Space and Time. Science. 2009 Dec 18; 326(5960):1694-1697. doi: 10.1126/science.1177486.</mixed-citation><mixed-citation xml:lang="en">Costello EK, Lauber CL, Hamady M, et al. Bacterial Community Variation in Human Body Habitats Across Space and Time. Science. 2009 Dec 18; 326(5960):1694-1697. doi: 10.1126/science.1177486.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Qin J, Li R, Raes J, et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature. 2010 Mar 4; 464(7285):59-65. doi: 10.1038/nature08821.</mixed-citation><mixed-citation xml:lang="en">Qin J, Li R, Raes J, et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature. 2010 Mar 4; 464(7285):59-65. doi: 10.1038/nature08821.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015; 37:47-55. doi: 10.1007/s00281-014-0454-4.</mixed-citation><mixed-citation xml:lang="en">Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015; 37:47-55. doi: 10.1007/s00281-014-0454-4.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gill SR, Pop M, DeBoy R, et al. Metagenomic Analysis of the Human Distal Gut Microbiome. Science. 2006 Jun 2; 312(5778):1355-1359. doi: 10.1126/science.1124234.</mixed-citation><mixed-citation xml:lang="en">Gill SR, Pop M, DeBoy R, et al. Metagenomic Analysis of the Human Distal Gut Microbiome. Science. 2006 Jun 2; 312(5778):1355-1359. doi: 10.1126/science.1124234.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009 Oct; Vol. 11 (10):2574-84. doi: 10.1111/j.1462-2920.2009.01982.x.</mixed-citation><mixed-citation xml:lang="en">Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009 Oct; Vol. 11 (10):2574-84. doi: 10.1111/j.1462-2920.2009.01982.x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 Jun 9; 9:123. doi: 10.1186/1471-2180-9-123.</mixed-citation><mixed-citation xml:lang="en">Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 Jun 9; 9:123. doi: 10.1186/1471-2180-9-123.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009 Dec; 7(12):887-94. doi: 10.1038/nrmicro2245.</mixed-citation><mixed-citation xml:lang="en">Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009 Dec; 7(12):887-94. doi: 10.1038/nrmicro2245.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bringiotti R, Lerardi E, Lovero R, et al. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol. 2014 Nov 15; 5(4):550-559. doi: 10.4291/wjgp.v5.i4.550</mixed-citation><mixed-citation xml:lang="en">Bringiotti R, Lerardi E, Lovero R, et al. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol. 2014 Nov 15; 5(4):550-559. doi: 10.4291/wjgp.v5.i4.550</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008 Sep; 57 (9):1185-1191. doi: 10.1136/gut.2007.122143.</mixed-citation><mixed-citation xml:lang="en">Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008 Sep; 57 (9):1185-1191. doi: 10.1136/gut.2007.122143.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016 Jan.; 14 (1):20-32. doi: 10.1038/nrmicro3552.</mixed-citation><mixed-citation xml:lang="en">Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016 Jan.; 14 (1):20-32. doi: 10.1038/nrmicro3552.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Petriz BA, Franco OL. Metaproteomics as a Complementary Approach to Gut Microbiota in Health and Disease. Front Chem. 2017 Jan 26; 5:4. doi: 10.3389/fchem.2017.00004.</mixed-citation><mixed-citation xml:lang="en">Petriz BA, Franco OL. Metaproteomics as a Complementary Approach to Gut Microbiota in Health and Disease. Front Chem. 2017 Jan 26; 5:4. doi: 10.3389/fchem.2017.00004.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yamashita T. Intestinal Immunity and Gut Microbiota in Atherogenesis. Journal of Atherosclerosis and Thrombosis. 2017; Vol. 24 No. 2:110-119. doi.org/10.5551/jat.38265</mixed-citation><mixed-citation xml:lang="en">Yamashita T. Intestinal Immunity and Gut Microbiota in Atherogenesis. Journal of Atherosclerosis and Thrombosis. 2017; Vol. 24 No. 2:110-119. doi.org/10.5551/jat.38265</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Escobedo G, Lopez-Ortiz E, Torres-Castro I. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance. Rev Investig Clin. 2014 Sep-Oct; 66(5):450-459.</mixed-citation><mixed-citation xml:lang="en">Escobedo G, Lopez-Ortiz E, Torres-Castro I. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance. Rev Investig Clin. 2014 Sep-Oct; 66(5):450-459.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Xuyun H, Guang J, Wei J, Houkai L. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. Int J Mol Sci. 2016 Mar; 17(3):300. doi: 10.3390/ijms17030300.</mixed-citation><mixed-citation xml:lang="en">Xuyun H, Guang J, Wei J, Houkai L. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. Int J Mol Sci. 2016 Mar; 17(3):300. doi: 10.3390/ijms17030300.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hua X, Goedert JJ, Pu A, et al. Allergy associations with the adult fecal microbiota: Analysis of the American Gut Project. EBioMedicine. 2015 Nov 27; 3:172-9. doi: 10.1016/j.ebiom.2015.11.038.</mixed-citation><mixed-citation xml:lang="en">Hua X, Goedert JJ, Pu A, et al. Allergy associations with the adult fecal microbiota: Analysis of the American Gut Project. EBioMedicine. 2015 Nov 27; 3:172-9. doi: 10.1016/j.ebiom.2015.11.038.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: Microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015 Nov; 42 (9):1051-63. doi: 10.1111/apt.13376.</mixed-citation><mixed-citation xml:lang="en">Wieland A, Frank DN, Harnke B, Bambha K. Systematic review: Microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2015 Nov; 42 (9):1051-63. doi: 10.1111/apt.13376.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Col of Nutrition. 2003 Feb; 22(1):56-63. doi: 10.1080/07315724.2003.10719276.</mixed-citation><mixed-citation xml:lang="en">Ishikawa H, Akedo I, Umesaki Y, et al. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Col of Nutrition. 2003 Feb; 22(1):56-63. doi: 10.1080/07315724.2003.10719276.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Saez-Lara M.J., Gomez-Llorente C., Plaza-Diaz J., Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015; 2015:505878. doi: 10.1155/2015/505878.</mixed-citation><mixed-citation xml:lang="en">Saez-Lara M.J., Gomez-Llorente C., Plaza-Diaz J., Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015; 2015:505878. doi: 10.1155/2015/505878.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ohkusa T. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002 Aug; 17 (8):849-53.</mixed-citation><mixed-citation xml:lang="en">Ohkusa T. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002 Aug; 17 (8):849-53.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuoka K, Mizuno S, Hayashi A, et al. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014; 63(4):69-74. doi: 10.2302/kjm.2014-0006-RE.</mixed-citation><mixed-citation xml:lang="en">Matsuoka K, Mizuno S, Hayashi A, et al. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014; 63(4):69-74. doi: 10.2302/kjm.2014-0006-RE.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ott SJ, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008; 103:643-648. doi:10.1111/j.1572-0241.2007.01592.x.</mixed-citation><mixed-citation xml:lang="en">Ott SJ, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008; 103:643-648. doi:10.1111/j.1572-0241.2007.01592.x.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Дубинкина В. Б., Тяхт А. В., Ильина Е. Н. и соавт. Метагеномный анализ таксономических и функциональных особенностей микробиоты кишечника у пациентов с синдромом алкогольной зависимости. // Биомедицинская химия. - 2015. - Т. 61 (Вып. 6). - С. 742-749.</mixed-citation><mixed-citation xml:lang="en">Дубинкина В. Б., Тяхт А. В., Ильина Е. Н. и соавт. Метагеномный анализ таксономических и функциональных особенностей микробиоты кишечника у пациентов с синдромом алкогольной зависимости. // Биомедицинская химия. - 2015. - Т. 61 (Вып. 6). - С. 742-749.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Michail S, Durbin M, Turner D, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis. 2012 Oct; 18 (10):1799-808. doi: 10.1002/ibd.22860.</mixed-citation><mixed-citation xml:lang="en">Michail S, Durbin M, Turner D, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis. 2012 Oct; 18 (10):1799-808. doi: 10.1002/ibd.22860.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Сафина Д. Д., Абдулхаков С. Р., Григорьева Т. В. и соавт. Влияние фармакотерапии на генетическое разнообразие биоценоза кишечника. // Гены &amp; клетки. - 2015. - Том X, № 4. - С. 80-85.</mixed-citation><mixed-citation xml:lang="en">Сафина Д. Д., Абдулхаков С. Р., Григорьева Т. В. и соавт. Влияние фармакотерапии на генетическое разнообразие биоценоза кишечника. // Гены &amp; клетки. - 2015. - Том X, № 4. - С. 80-85.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Khusnutdinova D, Grigoryeva T, Abdulkhakov S, Safina D. Gut Microbiome Shotgun Sequencing in Assessment of Microbial Community Changes Associated with H.pylori Eradication Therapy. BioNanoSci. 2016; Vol.6, Is.4:585-587. doi:10.1007/s12668-016-0285-y.</mixed-citation><mixed-citation xml:lang="en">Khusnutdinova D, Grigoryeva T, Abdulkhakov S, Safina D. Gut Microbiome Shotgun Sequencing in Assessment of Microbial Community Changes Associated with H.pylori Eradication Therapy. BioNanoSci. 2016; Vol.6, Is.4:585-587. doi:10.1007/s12668-016-0285-y.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Лоранская И. Д., Болдырева М. Н., Лаврентьева О. А., Мулухова Э. В. Пристеночная микрофлора кишечника. - М.: Прима принт, 2015. - 100 с.</mixed-citation><mixed-citation xml:lang="en">Лоранская И. Д., Болдырева М. Н., Лаврентьева О. А., Мулухова Э. В. Пристеночная микрофлора кишечника. - М.: Прима принт, 2015. - 100 с.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ардатская М. Д. Синдром избыточного бактериального роста. - М.: Форте принт, 2011. - 56 с.</mixed-citation><mixed-citation xml:lang="en">Ардатская М. Д. Синдром избыточного бактериального роста. - М.: Форте принт, 2011. - 56 с.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Барсук А. Л., Сумина А. В. Практическое обоснование низкой диагностической ценности микробиологического исследования кала на дисбактериоз. // Вопросы диагностики педиатрии. - 2009. - № 2. - С. 7-11.</mixed-citation><mixed-citation xml:lang="en">Барсук А. Л., Сумина А. В. Практическое обоснование низкой диагностической ценности микробиологического исследования кала на дисбактериоз. // Вопросы диагностики педиатрии. - 2009. - № 2. - С. 7-11.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Лоранская И. Д., Лаврентьева О. А. Функциональный анализ микробиоценоза желудочно-кишечного тракта // РМЖ. - 2011. - № 17. - С. 1057.</mixed-citation><mixed-citation xml:lang="en">Лоранская И. Д., Лаврентьева О. А. Функциональный анализ микробиоценоза желудочно-кишечного тракта // РМЖ. - 2011. - № 17. - С. 1057.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Tyakht AV, Kostryukova ES, Popenko AS, et al. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun. 2013; 4:2469. doi: 10.1038/ncomms3469.</mixed-citation><mixed-citation xml:lang="en">Tyakht AV, Kostryukova ES, Popenko AS, et al. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun. 2013; 4:2469. doi: 10.1038/ncomms3469.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Truong DT, Franzosa EA, Tickle TL, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nature Methods. 2015; 12:902-903. doi:10.1038/nmeth.3589.</mixed-citation><mixed-citation xml:lang="en">Truong DT, Franzosa EA, Tickle TL, et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nature Methods. 2015; 12:902-903. doi:10.1038/nmeth.3589.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Human Microbiome Project (HMP) Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun 13; 486 (7402):207-14. doi: 10.1038/nature11234.</mixed-citation><mixed-citation xml:lang="en">Human Microbiome Project (HMP) Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun 13; 486 (7402):207-14. doi: 10.1038/nature11234.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Pilarczyk-Zurek M, Strus M, Piotr PA, Heczko B. The dual role of Escherichia coli in the course of ulcerative colitis. BMC Gastroenterol. 2016; 16:128. doi: 10.1186/s12876-016-0540-2.</mixed-citation><mixed-citation xml:lang="en">Pilarczyk-Zurek M, Strus M, Piotr PA, Heczko B. The dual role of Escherichia coli in the course of ulcerative colitis. BMC Gastroenterol. 2016; 16:128. doi: 10.1186/s12876-016-0540-2.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Dabard J, Bridonneau C, Phillipe C, et al. Fons Ruminococcin A, a New Lantibiotic Produced by a Ruminococcus gnavus Strain Isolated from Human Feces. Appl Environ Microbiol. 2001 Sep; 67(9):4111-8.</mixed-citation><mixed-citation xml:lang="en">Dabard J, Bridonneau C, Phillipe C, et al. Fons Ruminococcin A, a New Lantibiotic Produced by a Ruminococcus gnavus Strain Isolated from Human Feces. Appl Environ Microbiol. 2001 Sep; 67(9):4111-8.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; Vol. 489 № 7415:220-230.</mixed-citation><mixed-citation xml:lang="en">Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; Vol. 489 № 7415:220-230.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006 Feb; 55(2):205-211. doi: 10.1136/gut.2005.073817.</mixed-citation><mixed-citation xml:lang="en">Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006 Feb; 55(2):205-211. doi: 10.1136/gut.2005.073817.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterology. 2010; 10:134. doi: 10.1186/1471-230X-10-134.</mixed-citation><mixed-citation xml:lang="en">Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterology. 2010; 10:134. doi: 10.1186/1471-230X-10-134.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
